TAG:
Results Act
From the Bench to Capitol Hill: Advocating for Laboratories
By Anne Tate | From the Volume XXXII, No. 16 – November 17, 2025 Issue
Many of us think our work ends at the clinical lab bench, but it doesn’t. Science extends into policy, advocacy, and the communities we serve. On October 21, I joined fellow members of the American Society of Clinical Laboratory Science (ASCLS) on Capitol Hill …
Congress is Listening. Labs Must Step Up on PAMA
By Scott Wallask | From the Volume XXXII, No. 16 – November 17, 2025 Issue
Just as The Dark Report went to press for this issue, the US federal government reopened after the longest shutdown in the country’s history. And while political pundits on both sides of the spectrum argued about who won and lost during the shutdown, it was clear that the cli…
After SALSA Hits a Wall, New RESULTS Act Steps In
By Scott Wallask | From the Volume XXXII, No. 14 – October 6, 2025 Issue
Upon reading the briefing in the last issue about the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, someof our members may have wondered,“What happened to SALSA?” SALSA, more formally known as the…
RESULTS Act Offers Another Chance at PAMA Relief
By R. Lewis Dark | From the Volume XXXII, No. 13 – September 15, 2025 Issue
OVER YOUR SHOULDER, YOU MAY HEAR THE CLOCK TICK…
Labs Directly Attack Upcoming PAMA Cuts
By Scott Wallask | From the Volume XXXII, No. 13 – September 15, 2025 Issue
CEO SUMMARY: The clinical laboratory industry once again finds itself advocating on Capitol Hill for proposed legislation to deal with an old problem: test reimbursement rate cuts under PAMA. While Congress has delayed scheduled rate cuts for the last several years, PAMA c…
CURRENT ISSUE
Volume XXXIII, No. 9 – July, 2026
Newsmaker Interview with Revvity’s Yves Dubaquie > How Specialty Diagnostic Tests Connect with Lab Customers: In this exclusive Q&A, Revvity’s Yves Dubaquie provides details about the in vitro diagnostics company’s priorities, including developing specialty tests and reviewing its business in China. Dubaquie also explains why clinical laboratories may need to consider hiring more technology-savvy workers in the future as the complexity of instruments grows.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized